« Al Fahr Photo Essay, Sights of the Fallujah Battle | Main | London Muslim Puts Film of Black Watch Deaths on Net »

November 14, 2004

A study of the Effectiveness of Commercially Available Drink Test Coasters for the Detection of "Date Rape" Drugs in Beverages.

Topics: Clinical Pharmacology

Reported in J Anal Toxicol 2004 Nov;28(8):685-8. Authors Meyers JE, Almirall JR.

Department of Chemistry and Biochemistry and International Forensic Research Institute, Florida International University, University Park, Miami, Florida 33199.

The use of illicit substances for the purpose of drug-facilitated sexual assault (DFSA) poses a significant problem. There has been an increase in public awareness of this problem, and a recent invention in the form of a drink coaster claims to detect whether or not a beverage has been spiked with a so-called date rape drug. A person is instructed to place a drop of the suspect beverage onto two spots of the test, smear gently, and wait until dry. If either spot turns to a darker blue color, then a possible date rape drug has been detected by the coaster test. In an effort to determine the effectiveness of the coasters, various drugs that have been associated with drug-facilitated sexual assault were tested at different concentrations in a variety of common alcoholic and non-alcoholic beverages. It was found that although the coasters do detect the presence of GHB and ketamine, two drugs that have been associated with DFSA, there are limiting factors such as the high concentration of the drugs required, hindrance of the reaction due to beverage matrix, and extensive time requirements for ketamine analysis.

Posted by Hyscience at November 14, 2004 8:13 AM

Articles Related to Clinical Pharmacology:

• Britain tests first Cannabis related medicine for rheumatoid arthritis - Nov 13, 2005
• Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma - May 26, 2005
• Cystatin C May Push Creatinine Off Risk Radar - May 19, 2005
• Cancer Treatment Success Stuns Scientists - May 16, 2005
• Antibody, cancer drug combo shows promise against breast tumors - May 16, 2005
• USC researchers determine mechanism of action of motexafin gadolinium (Xcytrin) - May 02, 2005
• Herceptin® Combined With Chemotherapy Improves Disease-Free Survival for Patients With Early-Stage Breast Cancer - Apr 26, 2005
• Selenium will have critical role in prostate cancer treatment - Fox Chase Cancer Center - Apr 21, 2005
• Traditional Medicine Derivatives Kill Cancer Cells - Apr 20, 2005
• Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds - Apr 19, 2005